GlassScriptPhysician profile
Sandeep Chennadi
NPI 1376869768
$1,791.33
in general payments reported to CMS, 2019-2025
25 companies · $238 in 2025
The $238 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $299 · 2021: $322 · 2022: $149 · 2023: $234 · 2024: $293 · 2025: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $764.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $456.15 | 2019-2025 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $210.92 | 2019-2025 | Tagrisso |
| Boehringer Ingelheim Pharmaceuticals, INC. | $146.80 | 2019-2021 | |
| United Therapeutics Corporation | $143.69 | 2020-2024 | Tyvaso |
| Ani Pharmaceuticals, INC. | $121.98 | 2025 | Purified Cortrophin Gel |
| Mallinckrodt Hospital Products INC. | $102.23 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $85.26 | 2019-2022 | |
| Amgen INC. | $69.78 | 2023-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $53.53 | 2020-2021 | |
| Genzyme Corporation | $51.04 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $48.75 | 2020-2022 | |
| Mylan Specialty L.P. | $39.84 | 2019-2021 | |
| Genentech USA, INC. | $35.76 | 2020-2021 | |
| Inspire Medical Systems, INC. | $35.43 | 2023 | Inspire |
| Harmony Biosciences LLC | $24.65 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $24.18 | 2023 | |
| Electromed, INC. | $18.72 | 2021 | |
| Janssen Pharmaceuticals, INC | $18.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $17.70 | 2019 | |
| Insmed, INC. | $17.13 | 2020 | |
| Philips North America LLC | $14.75 | 2020 | |
| Inogen, INC. | $14.68 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Chiesi USA, INC. | $14.45 | 2021 | |
| Resmed Corp | $13.74 | 2019 | |
| Sunovion Pharmaceuticals INC. | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Chennadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.